Skip to content
Sharism- Lifestyle
Author:
Adaptive Biotechnologies
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
June 16, 2026
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
June 16, 2026
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
May 29, 2026
←
Previous Page
1
2